Community/Retail

During the third annual Very Merry Meijer event, Meijer randomly selected 230 customers to receive their purchases free, and gave a $100 Meijer gift card to the cashier helping the customer.

AcelRX has submitted a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets).

Falls can cause significant mortality and morbidity in the aging population.

A PGY-2 Oncology Residency Director shares her advice for residents about remaining adaptable.

CVS Health has introduced Transform Diabetes Care, a new program available to help the company's pharmacy benefit management clients improve the health outcomes of their members, lower pharmacy costs through aggressive trend management, and decrease medical costs by improving medication adherence, A1C control and lifestyle management.

The United States Pharmacopeial Convention (USP) has published a quality standard for chlorhexidine gel, an antiseptic used to prevent life-threatening umbilical cord infections in newborns

The National Association of Chain Drug Stores (NACDS) is strategically advancing its highly effective, results-driven government affairs and public policy team by announcing the selection of William Tighe as vice president of federal government affairs and Amber Manko as director of federal government affairs.

Pharmacists must adjust their counseling approaches as more treatment options become available for patients with cancer.

A Memorial Sloan-Kettering pharmacist discusses the often complicated reimbursement process for oncology medications and appeals.

A hematology/oncology clinical pharmacist with Memorial Sloan-Kettering Cancer Center discusses the importance of early collaboration between pharmacists and oncologists in patient care.

Officials also announced the adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its enterprise-wide Pyxis ES System.

Third-generation medications for epilepsy are improving treatment options.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The Director of Pharmacy Services at Peninsula Regional Medical Center, chats with Pharmacy Times adding another layer of safety to compound parental nutrition doses.

Biohaven, the biopharmaceutical company, has received orphan drug designation from the FDA for BHV-0223, its drug candidate designed to treat amyotrophic lateral sclerosis (ALS).

You need to make sure that you realize what is influencing your career.

The U.S. Senate today passed the National Defense Authorization Act (NDAA), which includes a provision in Sec. 743 called the "Pilot Program for Prescription Drug Acquisition Cost Parity in the TRICARE Pharmacy Benefits Program.

It’s crucial for pharmacists to be aware of medications associated with high risk for error and harm to patients, and to look for best ways to implement practices for improving safety and patient care.

Presenting at a continuing education program is a rewarding experience.

Meniere's disease is a bothersome to disabling syndrome of the inner ear characterized by vertigo, hearing loss, tinnitus, and sensation of ear fullness.

Ready-to-use products don't involve human contact, giving them an advantage over other options in terms of safety and efficiency

Similar to smartphone updates, cumbersome drug library updates prevent the drug library from being useful to clinicians.

Regardless of some challenges, one health care system, which is comprised of 16 hospitals ranging from large academic settings to rural locations, has seen success with centralized PN compounding.

Health-system pharmacies can regulate cost-effective and efficient operations for parenteral nutrition compounding practices. Laura Mark, MS, PharmD, FASHP, led a tech talk at the Baxter Booth at the ASHP Midyear Clinical Meeting to discuss parenteral nutrition compounding practices.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses what pharmacists should keep in mind when treating patients with epilepsy.

ASHP honored several of their own this week at the Midyear meeting.

The FDA has expanded the indication of Roche’s bevacizumab (Avastin), allowing the drug to be used to treat several types of platinum-sensitive recurrent ovarian cancer.